Last reviewed · How we verify
NCT04103684
Steroids in Treatment of Viral Encephalitis
Phase 4 trial testing Methylprednisolone in Encephalitis, Viral in 100 participants. Status unknown.
30 March 2021
Quick facts
| Lead sponsor | Assiut University |
|---|---|
| Phase | Phase 4 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 30 March 2020 |
| Primary completion | 30 March 2021 |
| Estimated completion | 30 August 2021 |
Drugs / interventions tested
- Methylprednisolone (methylprednisolone) — full drug profile →
- Dexamethasone (dexamethasone) — full drug profile →
Conditions studied
- Encephalitis, Viral — all drugs for Encephalitis, Viral →
Sponsor
Assiut University
Who can join
Adults 1 Month to 18, any sex, with Encephalitis, Viral. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
acute viral encephalitis is used to describe restricted CNS involvement (namely, involvement of the brain, sparing the meninges)
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Steroids for the treatment of viral encephalitis: a systematic literature review and meta-analysis.
Hodzic E, Hasbun R, Granillo A, Tröscher AR, et al · · 2023 · cited 25× · PMID 37060361 · DOI 10.1007/s00415-023-11715-0
Verify or expand the search:
- PubMed search for NCT04103684
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Methylprednisolone
Trials testing the same drug.
- NCT07072585 — Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leuk · Phase 2, PHASE3 · not yet recruiting
- NCT07455396 — Pediatric Asthma Trial of Corticosteroid Heterogeneity (PATCH): Trial of Dexamethasone Versus Methylprednisolone for Ped · Phase 2 · not yet recruiting
- NCT07507643 — A Study of Methylprednisolone in People Having Liver Surgery · Phase 3 · recruiting
- NCT07357935 — Early Inflammatory-Immune Stratification and Precision Glucocorticoid Intervention in Acute Respiratory Failure Induced · Phase 1, PHASE2 · not yet recruiting
- NCT07265258 — A Study of Teprotumumab N01 in Subjects With Active Thyroid Eye Disease · Phase 4 · not yet recruiting
Other Assiut University trials
Trials by the same sponsor.
- NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
- NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
- NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
- NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
- NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04103684 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assiut University
- Last refreshed: 29 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04103684.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing